(Q40674506)

22 September 2017

1 reference

title

Thrombolysis in acute myocardial infarction: t-PA for everyone? (English)

1 reference

22 September 2017

1 reference

G S Reeder

1

1 reference

PubMed ID

8035639

22 September 2017

S L Kopecky

series ordinal

2

1 reference

PubMed ID

8035639

22 September 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

22 September 2017

1 reference

22 September 2017

69

1 reference

22 September 2017

8

1 reference

22 September 2017

796-799

1 reference

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Thrombolytic therapy for acute myocardial infarction. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Coronary Thrombolysis -- A Perspective for the Practicing Physician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Tailored thrombolytic therapy. A perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961102-1

10.1016/S0025-6196(12)61102-1

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

8035639